New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Sugar chains on cell surfaces direct cancer cells to die

Sugar chains on cell surfaces direct cancer cells to die

by Toho UniversityCancer cells highly expressing Lewis glycans on glycolipids are vulnerable to the death-inducing cytokine, TRAIL. Measurement of Lewis glycans on cancer cells could be a better predi
World medicine December 15,2023
Sugar chains on cell surfaces direct cancer cells to die

Sugar chains on cell surfaces direct cancer cells to die

by Toho UniversityCancer cells highly expressing Lewis glycans on glycolipids are vulnerable to the death-inducing cytokine, TRAIL. Measurement of Lewis glycans on cancer cells could be a better predi
World medicine December 15,2023
Tabrecta gains full FDA approval for non-small cell lung cancer

Tabrecta gains full FDA approval for non-small cell lung cancer

The U.S. Food and Drug Administration granted regular approval to capmatinib (Tabrecta) for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a genetic mutation leadi
World medicine December 15,2023
Tabrecta gains full FDA approval for non-small cell lung cancer

Tabrecta gains full FDA approval for non-small cell lung cancer

The U.S. Food and Drug Administration granted regular approval to capmatinib (Tabrecta) for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a genetic mutation leadi
World medicine December 15,2023
Efficacy of durvalumab for early-stage triple-negative breast cancer examined by race

Efficacy of durvalumab for early-stage triple-negative breast cancer examined by race

Among patients with early-stage triple-negative breast cancer (TNBC), the pathologic complete response (pCR) rate for durvalumab added to neoadjuvant chemotherapy is 46 percent, with similar rates for
World medicine December 15,2023
Efficacy of durvalumab for early-stage triple-negative breast cancer examined by race

Efficacy of durvalumab for early-stage triple-negative breast cancer examined by race

Among patients with early-stage triple-negative breast cancer (TNBC), the pathologic complete response (pCR) rate for durvalumab added to neoadjuvant chemotherapy is 46 percent, with similar rates for
World medicine December 15,2023
Robotic kidney cancer surgery shows desirable outcomes in study

Robotic kidney cancer surgery shows desirable outcomes in study

byUniversity of Texas Health Science Center at San AntonioIn thisillustration, a mass (depicted as jagged) is shown on a kidney (Level I, at left). The tumor extends up the inferior vena c
World medicine December 15,2023
Robotic kidney cancer surgery shows desirable outcomes in study

Robotic kidney cancer surgery shows desirable outcomes in study

byUniversity of Texas Health Science Center at San AntonioIn thisillustration, a mass (depicted as jagged) is shown on a kidney (Level I, at left). The tumor extends up the inferior vena c
World medicine December 15,2023
New method mass-produces antitumor cells to treat blood diseases and cancer

New method mass-produces antitumor cells to treat blood diseases and cancer

by Steve Martin,Purdue UniversityXiaoping Bao, Purdue University assistant professor from the Davidson School of Chemical Engineering. Credit: Xiaoping BaoA Purdue University chemical engineer h
World medicine December 15,2023
New method mass-produces antitumor cells to treat blood diseases and cancer

New method mass-produces antitumor cells to treat blood diseases and cancer

by Steve Martin,Purdue UniversityXiaoping Bao, Purdue University assistant professor from the Davidson School of Chemical Engineering. Credit: Xiaoping BaoA Purdue University chemical engineer h
World medicine December 15,2023
Alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

Alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

by Impact JournalsRepresentative images of PD-L1 (A), CD8 (B) and mucin (C) and staining. Credit: Baretti et al.A new research paper was published inOncotargeton July 28, 2022, entitled, &
World medicine December 15,2023
Alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

Alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

by Impact JournalsRepresentative images of PD-L1 (A), CD8 (B) and mucin (C) and staining. Credit: Baretti et al.A new research paper was published inOncotargeton July 28, 2022, entitled, &
World medicine December 15,2023
'CAR pooling' screens identify most effective cancer immunotherapy cells

'CAR pooling' screens identify most effective cancer immunotherapy cells

byUniversity of California, San FranciscoGeneration and screening of a pooled library of CARs with diverse signaling domains. (A) Our CARs combine an αCD19 ScFv (FMC63), a CD8 hinge and transmem
World medicine December 15,2023
'CAR pooling' screens identify most effective cancer immunotherapy cells

'CAR pooling' screens identify most effective cancer immunotherapy cells

byUniversity of California, San FranciscoGeneration and screening of a pooled library of CARs with diverse signaling domains. (A) Our CARs combine an αCD19 ScFv (FMC63), a CD8 hinge and transmem
World medicine December 15,2023
Research discovery may help diagnose and treat cancer and brain disorders

Research discovery may help diagnose and treat cancer and brain disorders

byQueen's University BelfastCredit: Unsplash/CC0 Public DomainResearchers at Queen's University Belfast have revealed how the pathway of an identified protein could lead to early diagnos
World medicine December 15,2023
Research discovery may help diagnose and treat cancer and brain disorders

Research discovery may help diagnose and treat cancer and brain disorders

byQueen's University BelfastCredit: Unsplash/CC0 Public DomainResearchers at Queen's University Belfast have revealed how the pathway of an identified protein could lead to early diagnos
World medicine December 15,2023
Prostate cancer cases risk being detected too late due to misleading focus on urinary problems, say experts

Prostate cancer cases risk being detected too late due to misleading focus on urinary problems, say experts

byUniversity of CambridgeCredit: Unsplash/CC0 Public DomainMen with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines a
World medicine December 15,2023
Prostate cancer cases risk being detected too late due to misleading focus on urinary problems, say experts

Prostate cancer cases risk being detected too late due to misleading focus on urinary problems, say experts

byUniversity of CambridgeCredit: Unsplash/CC0 Public DomainMen with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines a
World medicine December 15,2023
Can colorectal cancer be prevented?

Can colorectal cancer be prevented?

by Deb Balzer,Mayo ClinicMedical illustration of colon cancer. Credit: Mayo ClinicRegular screening is one of the most important ways to prevent colorectal cancer (colon and rectal)."Colore
World medicine December 15,2023
Can colorectal cancer be prevented?

Can colorectal cancer be prevented?

by Deb Balzer,Mayo ClinicMedical illustration of colon cancer. Credit: Mayo ClinicRegular screening is one of the most important ways to prevent colorectal cancer (colon and rectal)."Colore
World medicine December 15,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com